Why the study?
To highlight current understandings, historical development, and the rationale for changing principles of antibacterial prophylaxis for infective endocarditis, as well as clarify published international recommendations.
This review provides a comprehensive overview of the historical context and current international guidelines for antibiotic prophylaxis of infective endocarditis, highlighting the modern consensus to restrict its use to highest-risk patients.
Reviews evolving ABP recommendations for IE; leaves open need for outcome trials before practice shifts.
The presented review highlights current understandings of prophylaxis for infective endocarditis (IE). The historic aspects of the concept development of antibacterial prophylaxis (ABP) for IE, the main approaches and the rationale for changing the principles of ABP in recent years are described. There are detailed clarifications of published international and national recommendations, in particular, of European Society of Cardiology, National Institute for Health and Clinical Excellence, American Heart Association/American College of Cardiology and Japanese Circulation Society. The critical estimation of earlier adopted international guidelines with analysis of influence of partial or absolute ABP restrictions on the incidence of IE and its complications including fatality rate are presented.
No takes yet. Share an insight, caveat, or question.
Тарадин et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: